By crossed immunoelectrophoresis 36 different anode-migrating antigens were demonstrated in sonicated antigen preparations of Psetidomonas aeruiginosa. We numbered these antigens to establish a reference precipitin pattern. Antigen no. 31 was identified as the lipopolysaccharide (LPS) antigen, because it was found to be responsible for the 0-group specificity and because it reacted with anti-LPS monoclonal antibodies and with Limlllus amoebocyte lysate. Purified outer membrane proteins F (porin), H,, and I used as antigens formed precipitins with the reference antibodies, thus establishing their antigenicity. LPS that copurified with protein F and slightly contaminated protein H2 was detectable as an extra precipitin (antigen no. 31). The use of monoclonal antibodies specific for smooth LPS and rough LPS revealed different antigenic determinants in the LPS molecule and suggested that antigen no. 5 could be the core region of the LPS which is equivalent to the rough LPS. Antibodies against these outer membrane antigens were detected in patients with chronic P. aeruiginosa pneumonia and in patients with acute P. aertiginosa bacteremia. Antibodies with the same specificity were also found in rats chronically infected with P. aeriuginosa 7 days postinfection. This demonstrates the surface accessibility and antigenic reactivity of outer membrane antigens.
Pseiudomonas aeruiginosa is an opportunistic pathogen. It poses a major threat to the lives of a certain population of patients including burn patients (37) , cystic fibrosis patients (21) , and cancer patients (3, 4, 38, 40) . It has also become a major causative agent of nosocomial infections (4, 10, 39) . The poor prognosis for such patients and the intrinsic resistance of this organism to antibiotics has led to an interest in immunoprophylaxis. Lipopolysaccharide (LPS) and outer membrane proteins are macromolecules on the surface of this organism and therefore are logical potential vaccine candidates. Most of the antiPseudomonas vaccines developed to date (36) are LPS based, and they have been shown to provide limited serotype-specific protection. Also, the endotoxic properties of the LPS molecule have argued against the use of such vaccines in debilitated burn patients and in cystic fibrosis patients. It is therefore important to study the immunogenicity of other surface components as alternative vaccines. This aspect has been studied in other organisms such as Haemophilus infliuenzae (19, 29, 31) , Neisseria spp. (5, 45) , Shigella spp. (2) , and Salmonella typhimuirium (26) .
Previous studies from our group have shown that outer membrane proteins from different serotypes of P. aeruginosa are highly conserved (33) and that major outer membrane proteins interact with and mitogenically stimulate B lymphocytes (7) . In this present paper, we employed the technique of crossed immunoelectrophoresis, which is known for its high resolution, specificity, sensitivity, and usefulness for membrane analysis (20, 35, 42) , to study the immunogenicity of individual outer membrane components such as LPS, porin protein F, lipoprotein H2, and lipoprotein I. We have also demonstrated the use of monoclonal antibodies in specific identification of antigens from a complex antigen-antibody precipitin reference pattern. This information was further used to show the immunogenicity of these outer membrane antigens in model P. aeruiginosa infections of rats and in chronic and acute human pneumonias caused by P. aeruginosa. P. AERUGINOSA OUTER MEMBRANE ANTIGENS as a standard strain for the isolation of outer membrane proteins, antigen preparation, the immunization of rabbits and mice, and the pulmonary infection of rats. Strain AK1160, obtained from A. Kropinski (Queen's University, Kingston, Ontario), was a rough P. aeruginosa PAO derivative with defined LPS composition. It was used in this study for the production of rough LPS and the isolation of the corresponding monoclonal antibodies.
Generally, P. aeruginosa cultures were maintained on 1% (wt/vol) protease peptone no. 2 agar and used after growth in protease peptone no. 2 broth to an optical density at 660 nm of approximately 0.5 to 0.8. For antigen preparations, the bacteria were grown in Truche agar (22) , and for rat pulmonary infection studies, they were grown in modified Vogel and Bonner medium, which is known to enhance both exopolysaccharide production and microcolony formation (27) .
Outer membranes were isolated by the one-step procedure previously described (16) . The method of isolation of protein F (17) and proteins H2 and 1 (7) was exactly as described before.
The method of LPS isolation will be described elsewhere (R. P. Darveau and R. E. W. Hancock, submitted for publication). Briefly, bacterial cells were broken in the French press and dissolved in 2% sodium dodecyl sulfate-10 mM EDTA-20 mM Trishydrochloride (pH 7.0) at room temperature before the digestion of protein and subsequent ethanol precipitation. The resultant LPS was obtained in high yield (60 to 80% of cellular LPS) and was protein and nucleic acid free as judged by absorbance at 260 and 280 nm and lipid free as judged by fatty acid analysis. Smooth LPS was obtained from strain H103, and rough LPS was obtained from strain AK1160 by the same method. Quantitation of the LPS was performed by assaying for the LPS-specific sugar, 2-keto-3-deoxyoctonate (35) , assuming that this sugar was 4.3% by weight of LPS.
Immunogen preparation. For the immunization of rabbits, a culture grown for 12 h in modified Vogel and Bonner liquid medium from a 1% inoculum was subjected to Formalin killing by the standard method of Garvey et al. (15) . The immunogens were stored at -70°C in 1-ml samples.
Antigen preparation. Antigens were prepared by the method of H0iby and Axelsen (22) Another pool of antigens used in this study was heterologous to P. aeruginosa strain PAO-1. It was the standard antigen prepared from P. aeruginosa strains from the Habs antigen typing scheme 0-serogroups 3, 5, 6, 11, as described by H0iby and Axelsen (22) .
Animals and human sera. Six New Zealand white female rabbits were used; their preimmune sera were collected and pooled to check for any preimmune nonspecific antibodies. They were then immunized intramuscularly with 0.5 ml of immunogen dispersed in Freund incomplete adjuvant (Difco Laboratories) (1:1 ratio) twice weekly for the first 2 weeks. The animals were then rested for 1 week and immunized again at the end of week 3. At the end of week 4, the animals were bled to provide the "early response sera." Thereafter, they were immunized once every 2 weeks until 8 weeks. To ensure a good supply of sera, the hyperimmune response of these rabbits was maintained by immunizing them once a month, followed by bleeding 1 week later. All blood was obtained from the marginal vein of the ear. The response of the rabbits was usually adequate after an 8-week immunization schedule, with a bacterial agglutination titer of 1/5,120 or higher. All the sera collected were pooled and stored at -20°C until use. These sera were used to develop a reference pattern of crossed immunoelectrophoresis of PAO1-Ag.
Rat sera were obtained from Sprague-Dawley rats chronically infected with P. aeruginosa PAO-1 incorporated into agar beads. The method of the artificial infection was exactly as reported in a previous study (27) .
Two sources of human sera were used. One source was sera from patients with chronic P. aeruginosa pulmonary infections kindly supplied by L. E. Bryan (University of Calgary, Calgary). The second source was sera from leukemic patients with acute pneumonia and bacteremia caused by P. aeruginosa, kindly supplied by M. R. Moody (University of Maryland Cancer Center, Baltimore).
Immunoelectrophorectic 31 (Fig. 2B ). This indicated that antigen no. 31 could be related to the 0-group specificity of PAO-1. It should be noted that P. aeruginosa PAO-1 has a serotype classification of 0-group 5 according to the international typing scheme, which corresponds to 0-group 2 of the Habs typing scheme (23) . When rabbit antibodies against outer membranes of P. aeruginosa strain PAO-1 were introduced into the intermediate gel they also formed a precipitin with antigen no. 31 and displaced it from the reference pattern (Fig. 2C) 31 such that the combined precipitins spanned the width of the gel. This particular tail-like precipitin was identical to the antigen reacting with LPS rough core-specific monoclonal antibody MA3-9 (Fig. 2F ). In this case antigen no. 5 totally disappeared from the reference pattern.
Affinity absorption with Limulus amoebocyte lysate. At the lowest quantities of Limulus amoebocyte lysate added to the reaction mixture (1:1 ratio of PAO-1 antigen to Limulus amoebocyte lysate) the left part of antigen no. 31 disappeared (Fig. 3B) . Antigens no. 5 and 6 were also shown to be highly reactive to Limulus amoebocyte lysate (Fig 3B) . Two other antigens, 15 and 30, gradually decreased in the height of their precipitin peak with increasing amount of Limulus amoebocyte lysate added (Fig. 3C through F) . At the highest amount of Limulus amoebocyte lysate added (Fig. 3F) , the precipitin of antigen no. 15 was flattened to a line, and antigen no. 30 developed a "shoulder" on the left leg of its precipitin peak.
Analysis of outer membrane proteins, F, H, and I. The LPS that copurified with the purified protein F preparation formed a major precipitin peak in crossed immunoelectrophoresis ( indicated the close association of these macromolecules. A precipitin that formed a tail to the LPS antigen no. 31 ( Fig. 4B) closely resembled the one (probably antigen no. 5) that reacted with monoclonal antibody MA3-8 (Fig. 2F) . Two other minor precipitins at the bottom of the major peaks were also seen ( Fig. 4B ) and presumably represent contaminants present in low levels in the purified protein F preparation.
Crossed-line immunoelectrophoresis with the purified protein F added to the intermediate gel (Fig. 4C ) confirmed the identity of the dark precipitin in Fig. 4B as antigen no. 31. Other than the LPS associated with the purified protein F, this outer membrane protein did not form a line of identity with any antigens of the reference pattern ( Fig. 4A and C) . Monoclonal antibody MA4-4, found to have specificity against protein F, reacted to form a single precipitin peak with protein F (Fig. 4D ).
Crossed immunoelectrophoresis of purified protein I produced two major and three very minor precipitin peaks. This was indicative of either the presence of more than one antigenic determinant or of a slight contamination (Fig.   5B ). Antigen a in Fig. SB Crossed immunoelectrophoresis of protein H2 produced two precipitins (Fig. SD) . The darkly stained one resembled antigen no. 31; upon subsequent crossed-line immunoelectrophoresis with protein H2 in the intermediate gel, it was proved to be LPS. Antigen c in Fig. 5D has a relative mobility (Rf value) of 0.85, which is the same as that of antigen no. 10 in the reference pattern, but antigen no. 10 was unchanged during crossed-line immunoelectrophoresis of protein H2 (data not shown).
Immunogenicity of protein F in patients and animal models with P. aeruginosa infections. A total of 220 sera from 33 cystic fibrosis patients with chronic P. aeruginosa infections were shown to contain precipitating antibodies that recognized many of the P. aeruginosa antigens (Fig. 6A) . Ninety percent of these sera formed 10 or more precipitins with PAO-1 antigen or standard antigen, and 10% of these sera formed 5 to 9 precipitins. Invariably, these were precipitating antibodies against protein F (Fig. 6B) , regardless of whether the sera form more or less precipitin with PAO-1 antigen. As a control, 10 sera from eight healthy cystic fibrosis patients which had no detectable response against PAO-1 antigens were also studied. Anti-protein F antibodies could not be detected in these latter sera.
In the acute cases, antibodies against only one or two antigens of P. aeruginosa, including no. 31, could be observed a few days after the initial onset of P. aeruginosa bacteremia (Fig. 6C) . In 29 sera of four patients within the first 7 days of acute infections, precipitating antibodies against protein F were not detected. In contrast (Fig.  6D) , precipitating antibodies were formed against protein F by one of the patients approximately one month after the initial P. aeruginosa bacteremia. This showed that protein F was exposed to the host defense system and was immunogenic, in that it elicited antibody production.
In one of our previous studies (27) , we were able to use the rat model of chronic pulmonary infection developed by Cash et al. (6) to study the mode of growth of P. aeruginosa in rat lungs. Taking advantage of this useful system, we were able to monitor the immune response to various P. aeruginosa antigens. The series of crossed immunoelectrophoresis studies of protein F against these rat sera (Fig. 7A through G) was an effective titration of the production of anti-protein F antibodies from as early as 7 days and sustained until 56 days. The precipitin formed resembled that formed in reaction with monoclonal antibody MA4-4 (Fig. 7H) .
Immunogenicity of protein H2 and I in P. aeruginosa systems. Counterimmunoelectrophoresis was performed with proteins H2 and I as antigens. Antibodies that precipitated anti- gens present in protein H2 and I were found in patients with chronic P. aeruginosa infections, whereas antibodies were not detected in the first 7 days in acutely infected patients. Even though it varied from patient to patient, 14 days of acute infection was about the average time before the detection of antibodies toward these two proteins in patients' sera. In rats with artificial lung infections, antibodies to these proteins were formed as early as 7 days postinfection.
DISCUSSION
The PAO-1 antigen-antibody reference system described in this study contained 36 precipitins (Fig. 1) . Even though this number was less than the 55 precipitins reported by H0iby and Axelsen (22) , there were no major differences in the antibody produced against the more prominent antigens of P. aeruginosa. We were able to demonstrate this point by mixing antibodies from the two systems and by interchangeably using the two types of antigens in either of the reference systems (data not shown). However, one reason for these discrepancies could be the nature of the immunogens, since Formalin-fixed cells were used in this study rather than whole cell sonicates (22) . Thus, the bacterial antigens being presented to the humoral immune system will be those preserved on the bacterial cell surface (15) , thereby giving us a different reference pattern with emphasis on antibody production to those surface antigens most directly presented to the host. Both reference systems were adequate as base-line references to investigate antibody production to particular antigens.
From the full spectrum of antigens displayed in the PAO-1 reference system, the first outer 6 . Immunogenicity of protein F in patients with either chronic or acute P. aeruginosa infections. Antigens (Ag) used were PAO-1 antigens and protein F, and saline (NaCI) was added to the intermediate gels. and (iv) it reacted chemically with Limulus amoebocyte lysate. As a point of interest the mobility and morphology of antigen no. 31 in the reference pattern resembled the LPS of other gram-negative bacteria in crossed immunoelectrophoresis analyses (8, 11, 44) .
It was most intriguing to see how monoclonal antibodies MA1-8 (LPS 0-antigen specific) and MA3-8 (LPS rough core specific) reacted with their respective antigen, the LPS molecule ( Fig.  2E and F) . The appearance of a "tail" to the precipitin of antigen no. 31 31 closely resembled the description of the protein moeity (OEP) tightly associated with endotoxin, as described by Homma and co-workers (1, 24) . Its lack of interaction with MA3-8 could be interpreted as the masking of rough core determinants by protein associated with the LPS.
Thus far, the most sensitive method for the detection or quantitation of endotoxin has been the Limulus amoebocyte lysate test (14, 29 7 days, (B) 14 days, (C) 21 days, (D) 35 days, (E) 42 to confirm their immunogenicity. Precipitin formation was indicative that they elicited antibody response and were presented to the host's humoral immune system perhaps after a measure of antigen processing after phagocytosis of the immunogens by macrophages. However, they could not be identified in the reference PAO-1 antigen system. By performing sodium dodecyl sulfate-polyacrylamide gel electrophoresis, we were able to demonstrate that these antigens were present in the PAO-1 antigen preparation in extremely low quantities (data not shown). The small amount was probably too low to be detected in the cross immunoelectrophoresis system. When the quantities of these proteins were enriched by purification, they were easily recognizable by the antibodies raised against them (Fig. 4B , 5B, and 5D).
Patients harboring P. aeruginosa chronically were known to have high levels of antibody response to most of the antigens of this organism (21) , and Fernandes et al. (12) reported the detection of antibodies produced to two cell envelope proteins with apparent molecular weights of 58,500 and 37,500. In this study, we found antibodies to all three of the outer mem- brane proteins F, H2, and I in 220 sera from patients chronically infected with P. aeruginosa. In the chronic rat lung infection model, antibody response toward the three outer membrane proteins studied was detected at 7 days postinfection, in agreement with the data on chronically and acutely infected patients.
The frequency of P. aeruginosa infections was reported as high among acute leukemic patients (13) . This high frequency might be related to the deficiency in neutrophils (44) . Crowe et al. (9) , in a recent study, were able to detect antibodies against P. aeruginosa exoproducts like exotoxin A and proteases. In this study, we detected antibodies, in this type of patient, to the proteins F, H2, and I.
In conclusion, we have used affinity absorption with Limulus amoebocyte lysate and the exquisite specificity of monoclonal antibodies to identify the LPS antigen in immunogenic preparations of P. aeruginosa and to detect anti-LPS antibodies formed in response to injection of these immunogens or in response to animal model and human infections. We have shown that crossed immunoelectrophoresis can be used as an immunochemical tool to check the absolute purity and comparative antigenicity of bacterial cell surface macromolecules, and we have demonstrated that outer membrane proteins, F, H2, and I are immunogenic in animals and patients with both chronic and acute P. aeruginosa infections.
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